Triple agonist · larger vial

Retatrutide (50 mg)

$150 50 mg · per vial

For research use only. Not for human consumption.

Route

Subcutaneous

Documentation

On request

Shipping

Discreet

Handling

Inspected on arrival

Larger-vial format of the triple-agonist Retatrutide — lower per-mg cost for extended research protocols.

Watch

Deep research

Mechanism, common research protocols, evidence review, and cited primary literature for Retatrutide (50 mg) live on the full guide.

Also in Weight loss & metabolic

You might also research